89 related articles for article (PubMed ID: 25643514)
1. Expression of cytokeratin 7, 20, 14 in urothelial carcinoma and squamous cell carcinoma of the Egyprian urinary bladder cancer.
Hammam O; Wishahiz M; Khalil H; El Ganzouri H; Badawy M; Elkhquly A; Elesaily K
J Egypt Soc Parasitol; 2014 Dec; 44(3):733-40. PubMed ID: 25643514
[TBL] [Abstract][Full Text] [Related]
2. Impact of density of schistosomal antigen expression in urinary bladder tissue on the stratification, cell type, and staging, and prognosis of carcinoma of the bladder in Egyptian patients.
Wishahi M; Zakarya A; Hamamm O; Abdel-Rasol M; Badawy H; Elganzoury H; Ismail M; Elkhouly A; Meheina A
Infect Agent Cancer; 2014; 9():21. PubMed ID: 25018779
[TBL] [Abstract][Full Text] [Related]
3. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
4. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.
Gruver AM; Amin MB; Luthringer DJ; Westfall D; Arora K; Farver CF; Osunkoya AO; McKenney JK; Hansel DE
Arch Pathol Lab Med; 2012 Nov; 136(11):1339-46. PubMed ID: 23106579
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma.
Mhawech P; Uchida T; Pelte MF
Hum Pathol; 2002 Nov; 33(11):1136-40. PubMed ID: 12454820
[TBL] [Abstract][Full Text] [Related]
6. Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma.
Hayashi T; Sentani K; Oue N; Anami K; Sakamoto N; Ohara S; Teishima J; Noguchi T; Nakayama H; Taniyama K; Matsubara A; Yasui W
Histopathology; 2011 Oct; 59(4):710-21. PubMed ID: 22014052
[TBL] [Abstract][Full Text] [Related]
7. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.
Jones TD; Kernek KM; Yang XJ; Lopez-Beltran A; MacLennan GT; Eble JN; Lin H; Pan CX; Tretiakova M; Baldridge LA; Cheng L
Hum Pathol; 2005 Jul; 36(7):718-23. PubMed ID: 16084939
[TBL] [Abstract][Full Text] [Related]
8. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
[TBL] [Abstract][Full Text] [Related]
9. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus.
Yamada A; Sasaki H; Aoyagi K; Sano M; Fujii S; Daiko H; Nishimura M; Yoshida T; Chiba T; Ochiai A
Oncol Rep; 2008 Nov; 20(5):1021-7. PubMed ID: 18949396
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
11. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases.
Wasco MJ; Daignault S; Bradley D; Shah RB
Hum Pathol; 2010 Feb; 41(2):163-71. PubMed ID: 19800100
[TBL] [Abstract][Full Text] [Related]
12. Stratification of urinary bladder carcinoma based on immunohistochemical expression of CK5, CK14 and CK20.
Al-Sharaky DR; Abdelwahed M; Asaad N; Foda A; Abdou AG
J Immunoassay Immunochem; 2021 May; 42(3):236-251. PubMed ID: 33213275
[TBL] [Abstract][Full Text] [Related]
13. Primary carcinoma of renal calyx.
Williams PA; Mai KT
Pathol Res Pract; 2013 Oct; 209(10):654-61. PubMed ID: 23999038
[TBL] [Abstract][Full Text] [Related]
14. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation.
Fong A; Garcia E; Gwynn L; Lisanti MP; Fazzari MJ; Li M
Am J Clin Pathol; 2003 Jul; 120(1):93-100. PubMed ID: 12866378
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 Expression in Muscle-Invasive Urinary Bladder Urothelial Carcinoma According to Basal/Squamous-Like Phenotype.
Kim B; Lee C; Kim YA; Moon KC
Front Oncol; 2020; 10():527385. PubMed ID: 33365265
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation.
Samaratunga H; Delahunt B; Egevad L; Adamson M; Hussey D; Malone G; Hoyle K; Nathan T; Kerle D; Ferguson P; Nacey JN
Histopathology; 2016 Mar; 68(4):533-40. PubMed ID: 26211928
[TBL] [Abstract][Full Text] [Related]
17. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
[TBL] [Abstract][Full Text] [Related]
18. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.
Youssef R; Kapur P; Shariat SF; Arendt T; Kabbani W; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y
BJU Int; 2012 Oct; 110(7):961-6. PubMed ID: 22372762
[TBL] [Abstract][Full Text] [Related]
20. Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.
Youssef RF; Shariat SF; Kapur P; Kabbani W; Ghoneim T; King E; Cockburn A; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y
Hum Pathol; 2011 Mar; 42(3):347-55. PubMed ID: 21111452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]